Advertisement
QIAGEN Ingenuity
QIAGEN Ingenuity

The Scientist

» hearing, disease/medicine and microbiology

Most Recent

image: Week in Review: November 2–6

Week in Review: November 2–6

By | November 6, 2015

How Ebola hides from immune cells; gut microbes’ role in immunotherapy response; new mechanisms of hearing loss; butterflies use milkweed toxins to ward off predators

0 Comments

image: New Route to Hearing Loss Mapped

New Route to Hearing Loss Mapped

By | November 5, 2015

Deficiency in a protein called pejvakin makes inner ear cells more vulnerable to sound, unable to brace themselves against oxidative stress stimulated by noise. 

0 Comments

image: A Weighty Anomaly

A Weighty Anomaly

By | November 1, 2015

Why do some obese people actually experience health benefits?

3 Comments

image: Battling the Bulge

Battling the Bulge

By | November 1, 2015

Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | November 1, 2015

The Psychology of Overeating, The Hidden Half of Nature, The Death of Cancer, and The Secret of Our Success

0 Comments

image: Contributors

Contributors

By | November 1, 2015

Meet some of the people featured in the November 2015 issue of The Scientist.

0 Comments

image: Microbesity

Microbesity

By | November 1, 2015

Obesity appears linked to the gut microbiome. How and why is still a mystery—but scientists have plenty of ideas.

2 Comments

image: Weight's the Matter?

Weight's the Matter?

By | November 1, 2015

The causes and consequences of obesity are more complicated than we thought.  

0 Comments

image: Toward Protecting Participants’ Privacy

Toward Protecting Participants’ Privacy

By | October 29, 2015

Genomic data shared via the Beacon Project are vulnerable to privacy breaches, scientists show.

1 Comment

image: FDA OKs Herpesvirus to Treat Cancer

FDA OKs Herpesvirus to Treat Cancer

By | October 28, 2015

The US Food and Drug Administration’s approval of an engineered herpesvirus for the treatment of melanoma marks the first oncolytic virus to enter the market.

0 Comments

Advertisement
Lonza Group
Lonza Group

Popular Now

  1. First Data from Anti-Aging Gene Therapy
  2. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  3. Locating Language within the Brain
  4. Brain Keeps Watch During Sleep
Advertisement
SomaLogic
SomaLogic
Advertisement